BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 19932149)

  • 1. Genetic markers differentiating follicular thyroid carcinoma from benign lesions.
    Freitas BC; Cerutti JM
    Mol Cell Endocrinol; 2010 May; 321(1):77-85. PubMed ID: 19932149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns.
    Eszlinger M; Paschke R
    Mol Cell Endocrinol; 2010 Jun; 322(1-2):29-37. PubMed ID: 20083161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy.
    Williams MD; Suliburk JW; Staerkel GA; Busaidy NL; Clayman GL; Evans DB; Perrier ND
    Ann Surg Oncol; 2009 Nov; 16(11):3146-53. PubMed ID: 19727961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controversies in diagnostic approaches to the indeterminate follicular thyroid nodule.
    Carpi A; Nicolini A; Gross MD; Fig LM; Shapiro B; Fanti S; Rampin L; Polico C; Rubello D
    Biomed Pharmacother; 2005 Oct; 59(9):517-20. PubMed ID: 16202555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nondiagnostic thyroid fine needle aspiration cytology: outcome in surgical treatment.
    Tamez-Pérez HE; Gutiérrez-Hermosillo H; Forsbach-Sánchez G; Gómez-de Ossio MD; González-González G; Guzmán-López S; Tamez-Peña AL; Mora-Torres NE; González-Murillo EA
    Rev Invest Clin; 2007; 59(3):180-3. PubMed ID: 17910409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
    Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
    Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application.
    Saggiorato E; De Pompa R; Volante M; Cappia S; Arecco F; Dei Tos AP; Orlandi F; Papotti M
    Endocr Relat Cancer; 2005 Jun; 12(2):305-17. PubMed ID: 15947105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression.
    Rosen J; He M; Umbricht C; Alexander HR; Dackiw AP; Zeiger MA; Libutti SK
    Surgery; 2005 Dec; 138(6):1050-6; discussion 1056-7. PubMed ID: 16360390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TROP-2 expression in papillary thyroid carcinoma: Potential Diagnostic Utility.
    Simms A; Jacob RP; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2016 Jan; 44(1):26-31. PubMed ID: 26481593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration.
    Keutgen XM; Filicori F; Crowley MJ; Wang Y; Scognamiglio T; Hoda R; Buitrago D; Cooper D; Zeiger MA; Zarnegar R; Elemento O; Fahey TJ
    Clin Cancer Res; 2012 Apr; 18(7):2032-8. PubMed ID: 22351693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine-needle aspiration biopsy-RT-PCR expression analysis of prothymosin alpha and parathymosin in thyroid: novel proliferation markers?
    Letsas KP; Vartholomatos G; Tsepi C; Tsatsoulis A; Frangou-Lazaridis M
    Neoplasma; 2007; 54(1):57-62. PubMed ID: 17203893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large needle aspiration biopsy results of palpable thyroid nodules diagnosed by fine-needle aspiration as a microfollicular nodule with atypical cells or suspected cancer.
    Carpi A; Nicolini A; Righi C; Romani R; Di Coscio G
    Biomed Pharmacother; 2004; 58(6-7):351-5. PubMed ID: 15271415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMGA2 gene expression analysis performed on cytologic smears to distinguish benign from malignant thyroid nodules.
    Lappinga PJ; Kip NS; Jin L; Lloyd RV; Henry MR; Zhang J; Nassar A
    Cancer Cytopathol; 2010 Oct; 118(5):287-97. PubMed ID: 20597139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay.
    Nikiforov YE; Carty SE; Chiosea SI; Coyne C; Duvvuri U; Ferris RL; Gooding WE; Hodak SP; LeBeau SO; Ohori NP; Seethala RR; Tublin ME; Yip L; Nikiforova MN
    Cancer; 2014 Dec; 120(23):3627-34. PubMed ID: 25209362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic value of BRAFV600E and RET/PTC oncogenes in thyroid nodule aspirates].
    Guerra A; Carrano M; Angrisani E; Vitale M
    Recenti Prog Med; 2013; 104(7-8):415-9. PubMed ID: 24042420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of the Afirma Gene Expression Classifier in Hürthle Cell Thyroid Nodules Differs from Other Indeterminate Thyroid Nodules.
    Brauner E; Holmes BJ; Krane JF; Nishino M; Zurakowski D; Hennessey JV; Faquin WC; Parangi S
    Thyroid; 2015 Jul; 25(7):789-96. PubMed ID: 25962906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value of fine-needle aspiration biopsy (FNAB) in the differential diagnosis of the "cold" thyroid nodule].
    Passler C; Prager M; Scheuba C; Kaserer K; Flores JA; Vierhapper H; Niederle B
    Wien Klin Wochenschr; 1999 Mar; 111(6):240-5. PubMed ID: 10234779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follicular neoplasm of the thyroid--vanishing cytologic diagnosis?
    Kapur U; Wojcik EM
    Diagn Cytopathol; 2007 Aug; 35(8):525-8. PubMed ID: 17636488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nodule diagnosed as follicular patterned lesion: are biomarkers the promise?].
    Cerutti JM
    Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):832-42. PubMed ID: 17891248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.